Abstract:The emergence of subclonal mutations in high grade colorectal (CRC) tumors driving resistance against EGFR targeting is a major challenge, thus necessitating the discovery of alternative therapeutic strategies. Targeting aberrantly active WNT signaling provides an alternate route for CRC treatment. Here we show that the high DKC1 expression in CRC patients associates with advanced-stage disease regardless of RAS/RAF mutation status, indicating the potential of DKC1 as a pan-CRC therapeutic target. We show a direct regulation of DKC1 downstream of canonical WNT signaling and confirm it as one of the WNT targets. Mechanistically, DKC1 regulates several critical cellular processes such as telomere maintenance, pseudouridylation of ribosomal RNAs, ribosomal biogenesis, etc. However, its plausible association with cancer stemness remains largely unexplored. We generated stable DKC1 knockdown (DKC1-KD) cell lines, namely WiDr and Colo320HSR to investigate its role in cancer stemness and CRC progression. DKC1-KD cells show a significant reduction in the tumor sphere forming ability along with diminished cell surface expression of stemness markers. Using multiple publicly available gene expression datasets for CRC patients, we performed Gene Set Variation Analysis to characterize the association of DKC1 with upregulated gene signature of consensus molecular subtype 2 (CMS2) of CRC, which has been associated with the highest incidence rate and active WNT signaling. Further, Database for Annotation Visualization and Integrated Discovery tool-based analysis across these CRC patient samples striated based on DKC1 expression shows positive enrichment of biological processes related to cell cycle regulation. Consistently, we observed a G2/M phase cell cycle arrest upon silencing DKC1 in CRC cells. We also show that silencing DKC1 results in enhanced chemosensitivity with a remarkable reduction in lipid accumulation. Moreover, upon DKC1 silencing, an increase in epithelial marker E-cadherin and a decrease in mesenchymal marker N-cadherin expression was observed, suggesting its role in epithelial-to-mesenchymal transition (EMT) in CRC. Our findings demonstrate the role of DKC1 in regulating stemness, drug resistance, and EMT to drive CRC oncogenicity. Taken together, we highlight the role of DKC1 as the most suitable pan-CRC drug target by employing the potential of pharmacological inhibitors against WNT signaling. Citation Format: Shivansh Nigam, Ayush Praveen, Bushra Ateeq. WNT signaling-mediated DKC1 expression drives stemness associated with colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 6246.

Reduced CD146 Expression Promotes Tumorigenesis and Cancer Stemness in Colorectal Cancer Through Activating Wnt/β-catenin Signaling.

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells

CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Self-Renewal Molecular Mechanisms Of Colorectal Cancer Stem Cells

Silencing CXCR6 Promotes Epithelial-Mesenchymal Transition and Invasion in Colorectal Cancer by Activating the VEGFA/PI3K/AKT/mTOR Pathway

CD95 Promotes Stemness of Colorectal Cancer Cells by Lncrna MALAT1

Targeting CDK12 Obviates the Malignant Phenotypes of Colorectal Cancer Through the Wnt/β-catenin Signaling Pathway

Abstract 1542: Epithelial cell adhesion molecule induces canonical Wnt pathway to promote stemness in colorectal cancer

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

Abstract 6246: WNT signaling-mediated DKC1 expression drives stemness associated with colorectal cancer

Cd151 Promotes Colorectal Cancer Progression By A Crosstalk Involving Ceacam6, Lgr5 And Wnt Signaling Via Tgf Beta 1

CD11b/CD86 involved in the microenvironment of colorectal cancer by promoting Wnt signaling activation

CD51 Correlates with the TGF-beta Pathway and is a Functional Marker for Colorectal Cancer Stem Cells

Wnt Signaling Modulator DKK4 Inhibits Colorectal Cancer Metastasis Through an AKT/Wnt/β-catenin Negative Feedback Pathway.

Upregulation Of Cd147 Promotes Cell Invasion, Epithelial-To-Mesenchymal Transition And Activates Mapk/Erk Signaling Pathway In Colorectal Cancer

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1

Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer

Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells

MicroRNA‑8063 Targets Heterogeneous Nuclear Ribonucleoprotein AB to Inhibit the Self‑renewal of Colorectal Cancer Stem Cells Via the Wnt/β‑catenin Pathway.

FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization